TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07382167: A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Sponsor: Ardelyx · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 692 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$3,630,088

Rescue Site Savings

+$2,404,344

Unlock Full NCT07382167 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07382167 Rescue Dossier →